Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Saliva Is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2

View ORCID ProfileCody Callahan, Sarah Ditelberg, Sanjucta Dutta, Nancy Littlehale, Annie Cheng, Kristin Kupczewski, Danielle McVay, Stefan Riedel, View ORCID ProfileJames E. Kirby, Ramy Arnaout
doi: https://doi.org/10.1101/2021.04.21.21255621
Cody Callahan
aDepartment of Radiology
bDepartment of Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cody Callahan
Sarah Ditelberg
bDepartment of Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjucta Dutta
bDepartment of Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy Littlehale
dBeth Israel Deaconess Medical Center, Boston, MA, 02215 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annie Cheng
bDepartment of Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Kupczewski
bDepartment of Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danielle McVay
bDepartment of Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Riedel
bDepartment of Pathology
dBeth Israel Deaconess Medical Center, Boston, MA, 02215 USA
eHarvard Medical School, Boston, MA, 02215 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James E. Kirby
bDepartment of Pathology
dBeth Israel Deaconess Medical Center, Boston, MA, 02215 USA
eHarvard Medical School, Boston, MA, 02215 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James E. Kirby
Ramy Arnaout
bDepartment of Pathology
cDivision of Clinical Informatics, Department of Medicine
dBeth Israel Deaconess Medical Center, Boston, MA, 02215 USA
eHarvard Medical School, Boston, MA, 02215 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rarnaout@bidmc.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The continued need for molecular testing for SARS-CoV-2 and potential for self-collected saliva as an alternative to nasopharyngeal (NP) swabs for sample acquisition led us to compare saliva to NP swabs in an outpatient setting, without restrictions to avoid food, drink, smoking, or tooth-brushing.

Methods A total of 385 pairs of NP and saliva specimens were obtained, the majority from individuals presenting for initial evaluation, and were tested on two high-sensitivity RT-PCR platforms: the Abbott m2000 and Abbott Alinity m (both with limits of detection [LoD] of 100 copies of viral RNA/mL).

Results Concordance between saliva and NP was excellent overall (Cohen’s κ=0.93), for both initial and followup testing, for both platforms, and for specimens treated with guanidinium transport medium as preservative as well as for untreated saliva (κ=0.88-0.95). Viral loads were on average 16x higher in NP specimens than saliva specimens, suggesting that only the relatively small fraction of outpatients (∼8% in this study) who present with very low viral loads (<1,600 copies/mL from NP swabs) would be missed by testing saliva instead of NP swabs, when using sensitive testing platforms. Special attention was necessary to ensure leak-resistant specimen collection and transport.

Conclusions The advantages of self-collection of saliva, without behavioral restrictions, will likely outweigh a minor potential decrease in clinical sensitivity in individuals less likely to pose an infectious risk to others for many real-world scenarios, especially for initial testing.

Key points Saliva has comparable sensitivity and specificity to nasopharyngeal swabs for RT-PCR-based COVID-19 testing (concordance, κ=0.93; n=385 participants), albeit with slightly lower recovery of viral RNA. Treatment with a readily available guanidinium preservative within 24 hours of sample collection improves recovery.

Competing Interest Statement

This work was supported through a sponsored research agreement with Abbott Molecular. CC, SD, SD, NL, AC, KK, DM, SR, and RA have no other potential conflicts of interest to declare. JK has received reagents from Abbott Molecular for unrelated studies under a Covid-19 Diagnostics Evaluation Agreement.

Funding Statement

This work was supported through a sponsored research agreement with Abbott Molecular.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was reviewed and approved by institutional review board at the Beth Israel Deaconess Medical Center (BIDMC; IRB protocol no. 2020P000769).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

De-identified data is presented in Supplementary File 1. Supplementary Data can be found at (https://github.com/rarnaout/Covid_diagnostics).

https://github.com/rarnaout/Covid_diagnostics

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted April 23, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Saliva Is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Saliva Is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2
Cody Callahan, Sarah Ditelberg, Sanjucta Dutta, Nancy Littlehale, Annie Cheng, Kristin Kupczewski, Danielle McVay, Stefan Riedel, James E. Kirby, Ramy Arnaout
medRxiv 2021.04.21.21255621; doi: https://doi.org/10.1101/2021.04.21.21255621
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Saliva Is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2
Cody Callahan, Sarah Ditelberg, Sanjucta Dutta, Nancy Littlehale, Annie Cheng, Kristin Kupczewski, Danielle McVay, Stefan Riedel, James E. Kirby, Ramy Arnaout
medRxiv 2021.04.21.21255621; doi: https://doi.org/10.1101/2021.04.21.21255621

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (412)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (156)
  • Dermatology (97)
  • Emergency Medicine (247)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (392)
  • Epidemiology (8534)
  • Forensic Medicine (4)
  • Gastroenterology (381)
  • Genetic and Genomic Medicine (1739)
  • Geriatric Medicine (167)
  • Health Economics (370)
  • Health Informatics (1234)
  • Health Policy (618)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (369)
  • Infectious Diseases (except HIV/AIDS) (10271)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1666)
  • Nursing (97)
  • Nutrition (247)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (925)
  • Ophthalmology (262)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (110)
  • Palliative Medicine (40)
  • Pathology (249)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (246)
  • Primary Care Research (205)
  • Psychiatry and Clinical Psychology (1757)
  • Public and Global Health (3825)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (317)
  • Respiratory Medicine (518)
  • Rheumatology (207)
  • Sexual and Reproductive Health (164)
  • Sports Medicine (156)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (100)
  • Urology (74)